Missouri Court Grants Delay for Bayer's Roundup Settlement Hearing
By Adria Calatayud
A Missouri court granted a request to postpone to Sept. 14 a hearing to consider the final approval of Bayer's proposed $7.25 billion class settlement over its Roundup weedkiller, the company said.
Bayer and the class counsel filed a joint motion with the St. Louis city circuit court earlier in the week to reschedule the hearing, which had been previously scheduled for Aug. 19.
The court's order will give the parties more time to go through requests from plaintiffs to revoke their decisions to opt out of the settlement, as well as opt-out invalidity challenges, Bayer said.
The company previously said some plaintiffs who had opted out of the settlement sought to revoke their decisions after the U.S. Supreme Court sided with Bayer in a case over claims that it failed to warn consumers about Roundup's potential cancer risks.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
August 07, 2026 02:10 ET (06:10 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States